-
1
iPSC-derived HIOs are permissive to EBOV and MARV infection.
Foilsithe / Cruthaithe 2025Rannpháirtithe: -
2
Transcriptomic profiling of EBOV- and MARV-infected HCOs reveals viral load and shared and unique host responses.
Foilsithe / Cruthaithe 2025Rannpháirtithe: -
3
Delayed ISG induction in MARV infection and dysregulation of diarrhea-associated genes in EBOV- and MARV-infected human colonic organoids.
Foilsithe / Cruthaithe 2025Rannpháirtithe: -
4
BU310-Cre2 iPSC-derived HCOs are permissive to EBOV and MARV infection.
Foilsithe / Cruthaithe 2025Rannpháirtithe: -
5
Experimental overview and infection dynamics of primary cell-derived intestinal colonic (PCOs) organoids.
Foilsithe / Cruthaithe 2025Rannpháirtithe: -
6
Selective colocalization of EBOV VP35 with enterocytes in PCOs.
Foilsithe / Cruthaithe 2025Rannpháirtithe: -
7
iPSC-derived HIOs and HCOs are permissive to EBOV infection.
Foilsithe / Cruthaithe 2025Rannpháirtithe: -
8
Disruption of organoid integrity and impaired forskolin response in PCOs infected with EBOV or MARV at high MOI.
Foilsithe / Cruthaithe 2025Rannpháirtithe: -
9
Differential impact of EBOV and MARV on cAMP-mediated function in human gut organoids reveals region-specific loss of forskolin-induced swelling in HCOs.
Foilsithe / Cruthaithe 2025Rannpháirtithe: -
10
Directed differentiation of human iPSCs into region-specific intestinal (HIOs) and colonic (HCOs) organoids.
Foilsithe / Cruthaithe 2025Rannpháirtithe: -
11
Viral transcript production in EBOV- and MARV-infected HCOs at 1 and 3days post-infection.
Foilsithe / Cruthaithe 2025Rannpháirtithe: -
12
iPSC-derived HCOs are permissive to EBOV and MARV infection.
Foilsithe / Cruthaithe 2025Rannpháirtithe: -
13
Transcriptomic profiling of HIOs reveals viral replication and distinct host responses to EBOV and MARV infection.
Foilsithe / Cruthaithe 2025Rannpháirtithe: -
14
Virus- and region-specific epithelial immune activation in gut organoids at 3dpi.
Foilsithe / Cruthaithe 2025Rannpháirtithe: